rhbmp 2 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
95
Structured Review
R&D Systems
rhbmp 2
Rhbmp 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 224 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhbmp+2/Recombinant+Human+BMP-2+GMP+Protein%2C+CF/pm40695784-254-28-29
Average 95 stars, based on 224 article reviews
Rhbmp 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 224 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhbmp+2/Recombinant+Human+BMP-2+GMP+Protein%2C+CF/pm40695784-254-28-29
Average 95 stars, based on 224 article reviews
rhbmp 2 - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
other:Article Title: Aberrant EZHIP expression drives tumorigenesis in osteosarcoma Article Snippet: Chondrogenesis: Confluent cells in 96-well plates were induced with a cocktail of 3 ×10 − 8 M sodium selenite (Sigma, S5261), 10 μg/mL human transferrin (Sigma, T8158), 10–8 M dexamethasone, 100 ng/mL Concentration Assay:Article Title: Effects of Chemical Additives in Refolding Buffer on Recombinant Human BMP-2 Dimerization and the Bioactivity on SaOS-2 Osteoblasts Article Snippet: Briefly, the SaOS-2 cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Gibco; Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS), 1% penicillin–streptomycin (HyClone Laboratories Inc., Logan, UT) and maintained in a humidified incubator at 37 °C with 5% CO 2 . .. The SaOS-2 cells were seeded at a density of 0.8 × 10 3 cells/cm 2 in 24-well plates and treated either with 10 μL of 0.1 mg/mL refolded BMP-2 crude proteins in DMEM containing 2% FBS (a final concentration of 2 μg/mL crude proteins) or a 100 ng/mL commercially available Purification:Article Title: Effects of Chemical Additives in Refolding Buffer on Recombinant Human BMP-2 Dimerization and the Bioactivity on SaOS-2 Osteoblasts Article Snippet: Briefly, the SaOS-2 cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Gibco; Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS), 1% penicillin–streptomycin (HyClone Laboratories Inc., Logan, UT) and maintained in a humidified incubator at 37 °C with 5% CO 2 . .. The SaOS-2 cells were seeded at a density of 0.8 × 10 3 cells/cm 2 in 24-well plates and treated either with 10 μL of 0.1 mg/mL refolded BMP-2 crude proteins in DMEM containing 2% FBS (a final concentration of 2 μg/mL crude proteins) or a 100 ng/mL commercially available Positive Control:Article Title: Effects of Chemical Additives in Refolding Buffer on Recombinant Human BMP-2 Dimerization and the Bioactivity on SaOS-2 Osteoblasts Article Snippet: Briefly, the SaOS-2 cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Gibco; Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS), 1% penicillin–streptomycin (HyClone Laboratories Inc., Logan, UT) and maintained in a humidified incubator at 37 °C with 5% CO 2 . .. The SaOS-2 cells were seeded at a density of 0.8 × 10 3 cells/cm 2 in 24-well plates and treated either with 10 μL of 0.1 mg/mL refolded BMP-2 crude proteins in DMEM containing 2% FBS (a final concentration of 2 μg/mL crude proteins) or a 100 ng/mL commercially available Encapsulation:Article Title: Peptide Hydrogel for Sustained Release of Recombinant Human Bone Morphogenetic Protein-2 In Vitro Article Snippet: The PepGel used in this study contains PGmatrix solution A (crosslinking trigger reagent, including minerals, ions, and water) and a modified PGmatrix CDX solution B (PGmatrix-3D-shape, synthetic peptides based solubilized base membrane). .. To assess the effect of PepGel encapsulation on Article Title: Peptide Hydrogel for Sustained Release of Recombinant Human Bone Morphogenetic Protein-2 In Vitro. Article Snippet: The PepGel used in this study contains PGmatrix solution A (crosslinking trigger reagent, including minerals, ions, and water) and a modified PGmatrix CDX solution B (PGmatrix-3D-shape, synthetic peptides based solubilized base membrane). .. To assess the effect of PepGel encapsulation on In Vitro:Article Title: Peptide Hydrogel for Sustained Release of Recombinant Human Bone Morphogenetic Protein-2 In Vitro Article Snippet: The PepGel used in this study contains PGmatrix solution A (crosslinking trigger reagent, including minerals, ions, and water) and a modified PGmatrix CDX solution B (PGmatrix-3D-shape, synthetic peptides based solubilized base membrane). .. To assess the effect of PepGel encapsulation on Article Title: Peptide Hydrogel for Sustained Release of Recombinant Human Bone Morphogenetic Protein-2 In Vitro. Article Snippet: The PepGel used in this study contains PGmatrix solution A (crosslinking trigger reagent, including minerals, ions, and water) and a modified PGmatrix CDX solution B (PGmatrix-3D-shape, synthetic peptides based solubilized base membrane). .. To assess the effect of PepGel encapsulation on Expressing:Article Title: The mixed lineage leukemia 4 (MLL4) methyltransferase complex is involved in transforming growth factor beta (TGF-β)-activated gene transcription Article Snippet: Cells were treated with 10 μM SB431542 (#616461, Calbiochem) or 100 nM LDN193189 (SML0559, Sigma- Aldrich) to inhibit TGF-β or BMP signalling, respectively. .. After 24 h the cells were stimulated with 10 ng/mL TGF-β1 (#8915LC, Cell Signaling) or 10 ng/mL |